Caveolin-1 in oncogenic transformation, cancer, and metastasis

被引:448
作者
Williams, TM
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2005年 / 288卷 / 03期
关键词
caveolae; cellular signaling; tumor formation; cell invasiveness;
D O I
10.1152/ajpcell.00458.2004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Caveolae are 50- to 100-nm omega-shaped invaginations of the plasma membrane that function as regulators of signal transduction. Caveolins are a class of oligomeric structural proteins that are both necessary and sufficient for caveolae formation. Interestingly, caveolin-1 has been implicated in the pathogenesis of oncogenic cell transformation, tumorigenesis, and metastasis. Here, we review the available experimental evidence ( gleaned from cultured cells, animal models, and human tumor samples) that caveolin-1 (Cav-1) functions as a "tumor and/or metastasis modifier gene." Genetic evidence from the study of Cav-1( -/-) null mice and human breast cancer mutations [CAV-1 (P132L)] supports the idea that caveolin-1 normally functions as a negative regulator of cell transformation and mammary tumorigenesis. In contrast, caveolin-1 may function as a tumor promoter in prostate cancers. We discuss possible molecular mechanisms to explain these intriguing, seemingly opposing, findings. More specifically, caveolin-1 phosphorylation ( at Tyr14 and Ser80) and mutations ( P132L) may override or inactivate the growth inhibitory activity of the caveolin-scaffolding domain ( residues 82 - 101).
引用
收藏
页码:C494 / C506
页数:13
相关论文
共 136 条
[21]   p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression - Activation of Ras-MAP kinase and protein kinase A signaling cascades transcriptionally down-regulates caveolin-1 promoter activity [J].
Engelman, JA ;
Zhang, XL ;
Razani, B ;
Pestell, RG ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32333-32341
[22]  
Fine SW, 2001, AM J CLIN PATHOL, V115, P719
[23]   Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells [J].
Fiucci, G ;
Ravid, D ;
Reich, R ;
Liscovitch, M .
ONCOGENE, 2002, 21 (15) :2365-2375
[24]   Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation [J].
Fong, A ;
Garcia, E ;
Gwynn, L ;
Lisanti, MP ;
Fazzari, MJ ;
Li, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (01) :93-100
[25]   The expression of Rho proteins decreases with human brain tumor progression:: Potential tumor markers [J].
Forget, MA ;
Desrosiers, RR ;
Del Maestro, RF ;
Moumdjian, R ;
Shedid, D ;
Berthelet, F ;
Béliveau, R .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (01) :9-15
[26]   Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism [J].
Galbiati, F ;
Volonte, D ;
Liu, J ;
Capozza, F ;
Frank, PG ;
Zhu, L ;
Pestell, RG ;
Lisanti, MP .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (08) :2229-2244
[27]   Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade [J].
Galbiati, F ;
Volonté, D ;
Engelman, JA ;
Watanabe, G ;
Burk, R ;
Pestell, RG ;
Lisanti, MP .
EMBO JOURNAL, 1998, 17 (22) :6633-6648
[28]   Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells [J].
Gálvez, BG ;
Matías-Román, S ;
Yáñez-Mó, M ;
Vicente-Manzanares, M ;
Sánchez-Madrid, F ;
Arroyo, AG .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (02) :678-687
[29]   Dissecting the interaction between nitric oxide synthase (NOS) and caveolin - Functional significance of the NOS caveolin binding domain in vivo [J].
GarciaCardena, G ;
Martasek, P ;
Masters, BSS ;
Skidd, PM ;
Couet, J ;
Li, SW ;
Lisanti, MP ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25437-25440
[30]   NOVEL TYROSINE KINASE SUBSTRATES FROM ROUS-SARCOMA VIRUS-TRANSFORMED CELLS ARE PRESENT IN THE MEMBRANE SKELETON [J].
GLENNEY, JR ;
ZOKAS, L .
JOURNAL OF CELL BIOLOGY, 1989, 108 (06) :2401-2408